Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
XSAT:PHI'
s PB Ratio Range Over the Past 10 Years
Min: 1 Med: 15.52 Max: 439.52
Current: 1.02
During the past 13 years, Phase Holographic Imaging PHI AB's highest PB Ratio was 439.52. The lowest was 1.00. And the median was 15.52.
XSAT:PHI's PB Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.04
vs XSAT:PHI: 1.02
During the past 12 months, Phase Holographic Imaging PHI AB's average Book Value Per Share Growth Rate was 2495.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -25.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -23.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -19.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Phase Holographic Imaging PHI AB was 37.40% per year. The lowest was -55.10% per year. And the median was -10.60% per year.
Back to Basics: PB Ratio
Phase Holographic Imaging PHI AB (XSAT:PHI) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Phase Holographic Imaging PHI AB PB Ratio Related Terms
Phase Holographic Imaging PHI AB PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Phase Holographic Imaging PHI AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phase Holographic Imaging PHI AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phase Holographic Imaging PHI AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Phase Holographic Imaging PHI AB's PB Ratio falls into.
Phase Holographic Imaging PHI AB PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Phase Holographic Imaging PHI AB (XSAT:PHI) has a PB Ratio of 1.02 as of Jul. 20, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Phase Holographic Imaging PHI AB and its competitors. This is 93% below median its historical median of 15.52. Over the past decade, Phase Holographic Imaging PHI AB's PB Ratio has ranged from 1.00 to 439.52.
Is Phase Holographic Imaging PHI AB's PB Ratio too high?
Phase Holographic Imaging PHI AB's current PB Ratio of 1.02 is 93% below median its 10-year median of 15.52. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 439.52. The Medical Devices & Instruments industry median PB Ratio is 2.04. Phase Holographic Imaging PHI AB's value of 1.02 is 50% below this industry median. Overall, Phase Holographic Imaging PHI AB has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Phase Holographic Imaging PHI AB's PB Ratio compare to ABT and BSX?
Phase Holographic Imaging PHI AB's PB Ratio of 1.02 can be compared against companies in the Medical Devices & Instruments industry. The industry median PB Ratio is 2.04. Phase Holographic Imaging PHI AB's value of 1.02 is 50% below this benchmark. Historically, Phase Holographic Imaging PHI AB's own PB Ratio has ranged from 1.00 to 439.52 over the past decade. While the company's 10-year median is 15.52 vs. the industry median of 2.04, Phase Holographic Imaging PHI AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phase Holographic Imaging PHI AB's current PB Ratio of 1.02 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Phase Holographic Imaging PHI AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phase Holographic Imaging PHI AB's current PB Ratio is 1.02, which is 93% below median its own 10-year median of 15.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (XSAT:PHI) has a current PB Ratio of 1.02. The stock's GF Value™ is kr2.80, compared to a current price of kr0.53 — trading 81.1% below its estimated fair value. The current PB Ratio is 1.02, which is 93% below median its 10-year median of 15.52 and 50% below the Medical Devices & Instruments industry median of 2.04. Phase Holographic Imaging PHI AB's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (XSAT:PHI), the current PB Ratio is 1.02 as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Phase Holographic Imaging PHI AB (XSAT:PHI) Overvalued in 2026?
Based on GuruFocus' analysis, Phase Holographic Imaging PHI AB stock appears to be undervalued.
The current stock price of kr0.53 is trading 81.1% below its estimated GF Value™ of kr2.80.
Key valuation signals for XSAT:PHI:
PB Ratio: 1.02 (93% below median its 10-year median of 15.52)
GF Value™: kr2.80 vs. price of kr0.53 (81.1% below fair value)
Industry Position: 50% below the Medical Devices & Instruments median
No single metric tells the full story. See the XSAT:PHI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Phase Holographic Imaging PHI AB Business Description
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.
47GF Score
Get the complete analysis for XSAT:PHI
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:PHI has been successfully added to your 
